These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 32641056)
21. Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing mice. Abedi-Valugerdi M; Zheng W; Benkessou F; Zhao Y; Hassan M Int Immunopharmacol; 2017 Jun; 47():173-181. PubMed ID: 28411578 [TBL] [Abstract][Full Text] [Related]
22. Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes. Li L; Cao B; Liang X; Lu S; Luo H; Wang Z; Wang S; Jiang J; Lang J; Zhu G Oncogene; 2019 Apr; 38(15):2830-2843. PubMed ID: 30546089 [TBL] [Abstract][Full Text] [Related]
23. Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin. Suk Lee Y; Davila E; Zhang T; Milmoe HP; Vogel SN; Bromberg JS; Scalea JR Innate Immun; 2019 Jan; 25(1):46-59. PubMed ID: 30782043 [TBL] [Abstract][Full Text] [Related]
24. [Preparation of renal cancer vaccine of IL-12-anchored exosomes and its antitumor effect in vitro]. Zhang Y; Wu XH; Chen G; Luo CL; Zhang JM Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):339-43. PubMed ID: 20723430 [TBL] [Abstract][Full Text] [Related]
26. The blockage of Notch signalling promoted the generation of polymorphonuclear myeloid-derived suppressor cells with lower immunosuppression. Wang SH; Lu QY; Guo YH; Song YY; Liu PJ; Wang YC Eur J Cancer; 2016 Nov; 68():90-105. PubMed ID: 27728841 [TBL] [Abstract][Full Text] [Related]
27. Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8⁺ cell-derived exosomes. Nazimek K; Ptak W; Nowak B; Ptak M; Askenase PW; Bryniarski K Immunology; 2015 Sep; 146(1):23-32. PubMed ID: 25808106 [TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin regulates myeloid-derived suppressor cell-mediated immunosuppression via downregulation of nuclear factor-κB signaling. Kim NR; Kim YJ Cancer Med; 2019 Jan; 8(1):276-288. PubMed ID: 30592157 [TBL] [Abstract][Full Text] [Related]
29. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862 [TBL] [Abstract][Full Text] [Related]
30. TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression. Cao P; Sun Z; Zhang F; Zhang J; Zheng X; Yu B; Zhao Y; Wang W; Wang W Front Immunol; 2022; 13():919674. PubMed ID: 35874674 [TBL] [Abstract][Full Text] [Related]
31. TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host. Song G; Zhang Y; Tian J; Ma J; Yin K; Xu H; Wang S Front Immunol; 2021; 12():649020. PubMed ID: 33717204 [TBL] [Abstract][Full Text] [Related]
32. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer. Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487 [TBL] [Abstract][Full Text] [Related]
33. NKG2D ligand RAE1ε induces generation and enhances the inhibitor function of myeloid-derived suppressor cells in mice. Qian L; Liu Y; Wang S; Gong W; Jia X; Liu L; Ye F; Ding J; Xu Y; Fu Y; Tian F J Cell Mol Med; 2017 Sep; 21(9):2046-2054. PubMed ID: 28276625 [TBL] [Abstract][Full Text] [Related]
34. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer. Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521 [TBL] [Abstract][Full Text] [Related]
35. MDSC suppresses T cell antitumor immunity in CAC via GPNMB in a MyD88-dependent manner. Wang B; Wang L; Shang R; Xie L Cancer Med; 2024 Jan; 13(1):e6887. PubMed ID: 38140790 [TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients. Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766 [TBL] [Abstract][Full Text] [Related]
37. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538 [TBL] [Abstract][Full Text] [Related]
38. Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Nagaraj S; Nelson A; Youn JI; Cheng P; Quiceno D; Gabrilovich DI Cancer Res; 2012 Feb; 72(4):928-38. PubMed ID: 22237629 [TBL] [Abstract][Full Text] [Related]
39. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937 [TBL] [Abstract][Full Text] [Related]
40. TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes. Xiang X; Liu Y; Zhuang X; Zhang S; Michalek S; Taylor DD; Grizzle W; Zhang HG Am J Pathol; 2010 Oct; 177(4):1606-10. PubMed ID: 20802178 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]